Thursday, January 1, 2026 1/1/2026

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors

Award Number: R21CA262978
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/15/2021
PERIOD OF PERFORMANCE END DATE: 06/30/2025

Group Awards By:

View Award Description

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors - Primary brain tumors are the most common solid tumors and the leading cause of death from childhood cancer. In the era of molecular targeted therapy, greater than 60% of children with brain tumors are expected to become long-term survivors. Survival however is not without morbidity, with the majority of patients suffering from neurocognitive deficits that directly impact their educational attainment and work employment. Despite molecular tailored treatment regimens, radiation therapy remains a mainstay of cancer treatment in children with brain tumors and is considered the single most important risk factor for neurocognitive dysfunction. Radiation therapy leads to cellular injury that accelerates iron deposition in the brain. MR imaging with quantitative susceptibility mapping (QSM) is changing the landscape of neurodegenerative diseases such as Parkinson’s, where iron has been recently identified as a biomarker for disease burden as well as a target for disease therapy in the form of chelation therapy. Similar to patients with neurodegenerative disorders, our preliminary MR imaging data with QSM demonstrates accelerated iron deposition in our patients with brain tumors that received cranial radiation therapy (CRT). The purpose of this pilot study is to collect novel imaging and neuropsychological data in pediatric brain tumor survivors, exploring the continuum of short and long term effects of radiation therapy in order to investigate the direct association between radiation injury to the brain, iron accumulation and cognitive deficits. Our central hypothesis is that CRT in pediatric brain tumor survivors results in higher accumulation of iron in the brain (as quantified in vivo by QSM) as compared to patients without history of CRT, with increased brain iron independently correlating with worsening neurocognitive function. In this context, we advance the following specific aims: Specific Aim 1: To determine if cranial radiation therapy affects iron accumulation in the brain in a cross- sectional cohort of pediatric patients with posterior fossa tumors. Specific Aim 2: To explore the correlation between iron deposition and neuropsychological dysfunction in children with posterior fossa tumors. Currently, there is a disconnect between neuro-oncologists and their priority of curing the disease and prolonging survival versus neuropsychologists and their attempts of identifying and managing sequel of radiation induced neurocognitive deficits in survivors. Should this exploratory study provide evidence for the direct association between radiation injury to the brain, iron accumulation and cognitive dysfunction, this disconnect can potentially be bridged. This will ultimately lead to early identification of high-risk patients with radiation-induced injury and the implementation of risk-adaptive cancer therapy as well as the exploration of neuro-protective treatment options, such as iron chelation therapy, to reduce neurocognitive deficits in these patients throughout their lifespan.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$178 )
2026	2022	CHILDREN'S HOSPITAL LOS ANGELES	4650 W SUNSET BLVD	LOS ANGELES	CA	90027	LOS ANGELES	USA	Cancer Treatment Research	000	2	11/28/2025	NON-COMPETING CONTINUATION	-$178
														Subtotal = -$178

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	CHILDREN'S HOSPITAL LOS ANGELES	4650 W SUNSET BLVD	LOS ANGELES	CA	90027	LOS ANGELES	USA	Cancer Treatment Research	000	2	5/3/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $194,142 )
2022	2022	CHILDRENS HOSPITAL LOS ANGELES	4650 W SUNSET BLVD	LOS ANGELES	CA	90027	LOS ANGELES	USA	Cancer Treatment Research	000	2	7/5/2022	NON-COMPETING CONTINUATION	$194,142
														Subtotal = $194,142

Issue Date FY: 2021 ( Subtotal = $237,724 )
2021	2021	CHILDRENS HOSPITAL LOS ANGELES	4650 SUNSET BLVD	LOS ANGELES	CA	90027	LOS ANGELES	USA	Cancer Treatment Research	000	1	7/9/2021	NEW	$237,724
														Subtotal = $237,724

Grand Total All Awards = $431,688

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors

Award Number: R21CA262978

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/15/2021

PERIOD OF PERFORMANCE END DATE: 06/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer